My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Punj Lloyd gains after winning project
Apr 17,2017

The announcement was made during trading hours today, 17 April 2017.

Meanwhile, the S&P BSE Sensex was down 37.04 points, or 0.13% to 29,424.41.

On the BSE, 8.73 lakh shares were traded in the counter so far, compared with average daily volumes of 3.46 lakh shares in the past one quarter. The stock had hit a high of Rs 23.70 and a low of Rs 22.70 so far during the day. The stock hit a 52-week high of Rs 28.30 on 15 September 2016. The stock hit a record low of Rs 16.90 on 9 November 2016.

The stock had outperformed the market over the past one month till 13 April 2017, rising 10.51% compared with 0.22% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 10.51% as against Sensexs 8.16% rise.

The small-cap company has equity capital of Rs 66.85 crore. Face value per share is Rs 2.

Punj Lloyd said that its subsidiary, Dayim Punj Lloyd Construction Contracting Company, has been awarded an engineering, procurement, construction (EPC) contract - Clean Fuels Interfacing Facilities Project - on lump sum turn key (LSTK) basis in Yanbu, Saudi Arabia worth Rs 312 crore by the Yanbu Aramco Sinopec Refining Company (YASREF) in Saudi Arabia.

The project objective is to interface YASREF with the Aramco Yanbu Refinery to supply low sulphur clean transportation fuel - diesel and gasoline - for domestic distribution. In addition, the pipeline system will also contain provision to transport YASREF refined products to the western regional pipeline hub.

With this order, the groups order backlog stands at Rs 19929 crore. The order backlog is the value of unexecuted orders on 31 December 2016 plus new orders received after that date, Punj Lloyd said in a release.

Punj Lloyd reported net loss of Rs 231.81 crore in Q3 December 2016 as against net loss of Rs 309.31 crore in Q3 December 2015. Net sales declined 1.02% to Rs 992.90 crore in Q3 December 2016 over Q3 December 2015.

The Punj Lloyd Group is a diversified international conglomerate offering EPC services in energy and infrastructure along with engineering and manufacturing capabilities in the defence sector.

Powered by Capital Market - Live News

Indian Hume Pipe jumps after winning order
Apr 17,2017

The announcement was made after market hours on Thursday, 13 April 2017.

Meanwhile, the S&P BSE Sensex was down 4.83 points, or 0.02% to 29,456.62.

On the BSE, 11,000 shares were traded in the counter so far, compared with average daily volumes of 5,298 shares in the past one quarter. The stock had hit a high of Rs 428.55 and a low of Rs 420.95 so far during the day. The stock hit a record high of Rs 459 on 9 February 2017. The stock hit a 52-week low of Rs 160.50 on 25 May 2016.

The stock had outperformed the market over the past one month till 13 April 2017, rising 5.17% compared with 0.22% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 8.64% as against Sensexs 8.16% rise.

The small-cap company has equity capital of Rs 9.69 crore. Face value per share is Rs 2.

Indian Hume Pipe Company said it secured work order of Rs 177.22 crore from Bangalore Water Supply and Sewerage Board, Bangalore for execution of the Work of Providing Water Supply Facilities to Byatarayanapura Zone coming under 110 villages of Bruhat Bengaluru Mahanagar Palike (BBMP). The project is to be completed within 24 months from signing of agreement with them. The agreement will be signed in due course.

Indian Hume Pipe Companys net profit rose 182.09% to Rs 17.80 crore on 105.30% rise in net sales to Rs 406.50 crore in Q3 December 2016 over Q3 December 2015.

Indian Hume Pipe Company is engaged in the business of providing integrated water supply schemes including manufacturing, laying and jointing of pipelines of various pipe materials which provide infrastructure facility for development of water supply and irrigation projects.

Powered by Capital Market - Live News

Omkar Speciality Chemicals extends gains
Apr 17,2017

Meanwhile, the S&P BSE Sensex was up 1.61 points or 0.01% at 29,463.06.

On the BSE, 49,000 shares were traded on the counter so far as against the average daily volumes of 41,119 shares in the past one quarter. The stock had hit a high of Rs 181.90 and a low of Rs 176 so far during the day.

The stock had hit a 52-week high of Rs 197.50 on 13 April 2016 and a 52-week low of Rs 130.05 on 9 November 2016. It had outperformed the market over the past one month till 13 April 2017, advancing 12.98% compared with the Sensexs 1.78% rise. The scrip had, however, underperformed the market over the past one quarter, gaining 7.34% as against the Sensexs 8.16% rise.

The small-cap company has equity capital of Rs 20.58 crore. Face value per share is Rs 10.

Shares of Omkar Speciality Chemicals have risen 8.92% in two trading sessions from its closing of Rs 165.25 on 12 April 2017, after the company announced during market hours on Thursday, 13 April 2017 that the National Company Law Tribunal (NCLT) approved scheme of arrangement between the company and five other firms. The stock had surged 6.14% to settle at Rs 175.40 on 13 April 2017. The stock market was shut on Friday, 14 April 2017, for a holiday.

Omkar Speciality Chemicals announced that the NCLT, Mumbai Bench passed an order on 13 April 2017 sanctioning the composite scheme of arrangement between Omkar Speciality Chemicals, Lasa Laboratory, Urdhwa Chemicals Company, Rishichem Research, Desh Chemicals and Lasa Supergenerics and their respective shareholders and creditors.

On a consolidated basis, net profit of Omkar Speciality Chemicals rose 11.8% to Rs 10.51 crore on 16% rise in net sales to Rs 125.69 crore in Q3 December 2016 over Q3 December 2015.

Omkar Speciality Chemicals is primarily engaged in the production of specialty chemicals and pharma intermediates.

Powered by Capital Market - Live News

IOL Chemicals rallies 20.9% in two sessions
Apr 17,2017

Meanwhile, the S&P BSE Sensex was up 17.95 points, or 0.06% at 29,479.40. The S&P BSE Small-cap index was up 59.99 points, 0.4% at 14,941.15.

On the BSE, 92,000 shares were traded on the counter so far as against the average daily volumes of 1.01 lakh shares in the past one quarter. The stock had hit a high of Rs 72.90 and a low of Rs 69.90 so far during the day.

The stock had hit a 52-week high of Rs 155.95 on 23 September 2016 and a 52-week low of Rs 58.95 on 12 April 2017. The stock had underperformed the market over the past one month till 13 April 2017, declining 26.66% compared with the Sensexs 1.78% rise. The scrip had also underperformed the market over the past one quarter declining 33.6% as against the Sensexs 8.16% rise.

The small-cap company has equity capital of Rs 56.21 crore. Face value per share is Rs 10.

Shares of IOL Chemicals & Pharmaceuticals have rallied 20.9% in two trading sessions from its close of Rs 60.30 on 12 April 2017, after the company announced after market hours on Wednesday, 12 April 2017 that it received EUGMP Certification from National Institute of Pharmacy and Nutrition, Hungary, for its product Ibuprofen, Lamotrigine, Metformin Hydrochloride confirming compliance with principals of Good Manufacturing Practices as provided by European Union Legislation.

This will facilitate the company to expand its product portfolio in the European market. The stock surged by the 10% upper circuit level to settle at Rs 66.30 on Thursday, 13 April 2017. The stock market was closed on Friday, 14 April 2017, for a holiday.

IOL Chemicals & Pharmaceuticals reported net profit of Rs 1.02 crore in Q3 December 2016, as against net loss of Rs 6.22 crore in Q3 December 2015. Net sales rose 27.9% to Rs 183.03 crore in Q3 December 2016 over Q3 December 2015.

IOL Chemicals & Pharmaceuticals is one of the leading generic pharmaceuticals companies and is significant player in the speciality chemicals space.

Powered by Capital Market - Live News

Manaksia Industries slumps after weak Q4 results
Apr 17,2017

The result was announced on Saturday, 15 April 2017.

Meanwhile, the S&P BSE Sensex was down 12.64 points, or 0.04% to 29,448.81.

On the BSE, 1.35 lakh shares were traded in the counter so far, compared with average daily volumes of 26,452 shares in the past one quarter. The stock had hit a high of Rs 40.95 so far during the day, which is also a record high for the counter. The stock hit a 52-week low of Rs 3.20 on 9 May 2016.

The stock had outperformed the market over the past one month till 13 April 2017, rising 39.29% compared with 0.22% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 105.16% as against Sensexs 8.16% rise.

The small-cap company has equity capital of Rs 6.55 crore. Face value per share is Re 1.

Manaksia Industries net profit rose 45.79% to Rs 27.89 crore on 20.89% decline in net sales to Rs 124.50 crore in the year ended March 2017 over the year ended March 2016.

Manaksia Industries is engaged in the business of metal packaging products and aluminum semi rigid containers.

Powered by Capital Market - Live News

Bajaj Corp slides after weak Q4 results
Apr 17,2017

The result was announced at the fag end of the trading session on Thursday, 13 April 2017. The market was shut on Friday, 14 April 2017, on account of public holiday.

Meanwhile, the S&P BSE Sensex was down 15.88 points or 0.05% at 29,445.57. The S&P BSE Mid-Cap index was up 22.96 points or 0.16% at 14,373.92.

On the BSE, 13,000 shares were traded on the counter so far as against the average daily volumes of 9,692 shares in the past one quarter. The stock had hit a high of Rs 410.35 and a low of Rs 397 so far during the day.

The stock had hit a 52-week high of Rs 436 on 10 October 2016 and a 52-week low of Rs 340 on 12 December 2016. It had outperformed the market over the past one month till 13 April 2017, advancing 16.85% compared with the Sensexs 1.78% rise. The scrip had also outperformed the market over the past one quarter gaining 11.51% as against the Sensexs 8.16% rise.

The mid-cap company has equity capital of Rs 14.75 crore. Face value per share is Rs 1.

Bajaj Corp is an FMCG company with major brands in hair care category.

Powered by Capital Market - Live News

DCB Bank tumbles after weak Q4 results
Apr 17,2017

The result was announced on Friday, 14 April 2017. The market was shut on Friday, 14 April 2017, on account of public holiday.

Meanwhile, the S&P BSE Sensex was down 2.24 points, or 0.01% to 29,459.21.

On the BSE, 2.63 lakh shares were traded in the counter so far, compared with average daily volumes of 3.07 lakh shares in the past one quarter. The stock had hit a high of Rs 174 and a low of Rs 167.60 so far during the day. The stock hit a record high of Rs 183.40 on 12 April 2017. The stock hit a 52-week low of Rs 87.40 on 24 May 2016.

The stock had outperformed the market over the past one month till 13 April 2017, rising 9.34% compared with 0.22% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 45% as against Sensexs 8.16% rise.

The mid-cap company has equity capital of Rs 285.36 crore. Face value per share is Rs 10.

DCB Banks net profit rose 2.65% to Rs 199.68 crore on 21.2% rise in total income to Rs 2325.60 crore in the year ended March 2017 over the year ended March 2016.

The banks gross non-performing assets (NPAs) stood at Rs 254.20 crore as on 31 March 2017 as against Rs 227.93 crore as on 30 December 2016 and Rs 197.38 crore as on 31 March 2016.

The ratio of gross NPAs to gross advances stood at 1.59% as on 31 March 2017 as against 1.55% as on 31 December 2016 and 1.51% as on 31 March 2016.

The ratio of net NPAs to net advances stood at 0.79% as on 31 March 2017 as against 0.74% as on 31 December 2016 and 0.75% as on 31 March 2016.

The banks provisions and contingencies (excluding tax provisions) rose 24.51% to Rs 33.93 crore in Q4 March 2017 over Q4 March 2016.

DCB Bank is a new generation private sector bank with 262 branches across 18 states and 2 union territories.

Powered by Capital Market - Live News

Reliance Power gains after Q4 results
Apr 17,2017

The result was announced on Friday, 14 April 2017. The stock market was shut on Friday, 14 April 2017, on account of public holiday.

Meanwhile, the S&P BSE Sensex was down 39.44 points, or 0.13% to 29,422.01.

On the BSE, 5.35 lakh shares were traded in the counter so far, compared with average daily volumes of 64.56 lakh shares in the past one quarter. The stock had hit a high of Rs 48.60 and a low of Rs 47.20 so far during the day.

The stock hit a 52-week high of Rs 56.45 on 26 July 2016. The stock hit a 52-week low of Rs 38.20 on 24 November 2016.

The stock had outperformed the market over the past one month till 13 April 2017, rising 0.96% compared with 0.22% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 5.81% as against Sensexs 8.16% rise.

The large-cap company has equity capital of Rs 2805.13 crore. Face value per share is Rs 10.

The companys consolidated net profit rose 23.31% to Rs 1104.16 crore on 0.94% rise in net sales to Rs 10395.65 crore in the year ended March 2017 over the year ended March 2016.

Reliance Power on its own and through its subsidiaries has a large portfolio of power generation capacity, both in operation as well as capacity under development.

Powered by Capital Market - Live News

Dr Reddys Lab advances as USFDA completes audit of plant
Apr 17,2017

The announcement was made on Friday, 14 April 2017. The market was shut on Friday, 14 April 2017, on account of public holiday.

Meanwhile, the S&P BSE Sensex was down 62.23 points or 0.21% at 29,399.22.

On the BSE, 30,000 shares were traded on the counter so far as against the average daily volumes of 43,992 shares in the past one quarter. The stock had hit a high of Rs 2,721.95 and a low of Rs 2,696.15 so far during the day.

The stock had hit a 52-week high of Rs 3,689 on 20 July 2016 and a 52-week low of Rs 2,560 on 22 March 2017. It had underperformed the market over the past one month till 13 April 2017, sliding 2.88% compared with the Sensexs 1.78% rise. The scrip had also underperformed the market over the past one quarter declining 11.45% as against the Sensexs 8.16% rise.

The large-cap company has equity capital of Rs 82.87 crore. Face value per share is Rs 5.

Dr Reddys Laboratories (DRL) announced that the audit of its API Srikakulam plant in Andhra Pradesh by the US Food and Drug Administration (USFDA) was completed on Friday, 14 April 2017, with no observations.

Dr Reddys Laboratories consolidated net profit fell 15.9% to Rs 492.30 crore on 6.6% fall in net sales to Rs 3706.50 crore in Q3 December 2016 over Q3 December 2015.

Dr Reddys Laboratories is an integrated global pharmaceutical company.

Powered by Capital Market - Live News

Gravity grips Tube Investments on profit booking
Apr 13,2017

Meanwhile, the S&P BSE Sensex was down 175.70 points or 0.59% at 29,467.78.

On BSE, so far 26,000 shares were traded in the counter as against average daily volume of 18,199 shares in the past one quarter. The stock hit a high of Rs 717.35 and a low of Rs 664 so far during the day. The stock had hit a record high of Rs 730 on 12 April 2017. The stock had hit a 52-week low of Rs 401 on 13 April 2016.

The stock had outperformed the market over the past one month till 12 April 2017, rising 16.7% compared with 0.68% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 22.28% as against Sensexs 8.79% rise.

The large-cap company has an equity capital of Rs 37.49 crore. Face value per share is Rs 2.

Tube Investments of Indias net profit surged 67.4% to Rs 27.47 crore on 8.19% growth in total income to Rs 974.39 crore in Q3 December 2016 over Q3 December 2015.

Tube Investments of India is primarily engaged in the production of steel tubes, cold rolled steel strips and metal sections, as well as bicycles and all critical bicycle components. Its unit TI Cycles is a leading bicycle maker in India.

Powered by Capital Market - Live News

IFCI drops after revising benchmark rate
Apr 13,2017

The announcement was made after market hours yesterday, 12 April 2017.

Meanwhile, the S&P BSE Sensex was down 167.11 points, or 0.56%, to 29,476.37. The S&P BSE Mid-Cap index was up 3.12 points, or 0.02%, to 14,349.99.

On the BSE, so far 4.72 lakh shares were traded in the counter, compared with average daily volumes of 13.59 lakh shares in the past one quarter. The stock had hit a high of Rs 29.90 and a low of Rs 29.20 so far during the day. The stock hit a 52-week high of Rs 32.60 on 3 February 2017. The stock hit a 52-week low of Rs 21.30 on 22 November 2016.

The stock had outperformed the market over the past one month till 12 April 2017, rising 4.96% compared with 0.68% rise in the Sensex. The scrip also outperformed the market in past one quarter, gaining 5.34% as against Sensexs 8.79% rise.

The mid-cap company has equity capital of Rs 1662.04 crore. Face value per share is Rs 10.

IFCI also slashed its short term benchmark rate from 8.35% per annum to 8.8% per annum with monthly rests with effect from 13 April 2017.

IFCI reported a net loss of Rs 45.17 crore in Q3 December 2016 compared with net profit of Rs 154.33 crore in Q3 December 2015. IFCIs total income fell 32.9% to Rs 635.55 crore in Q3 December 2016 over Q3 December 2015.

IFCI is a financial institution catering to the long-term finance needs of the industrial sector.

Powered by Capital Market - Live News

HealthCare Global Enterprises spurts after bulk deal
Apr 13,2017

Meanwhile, the S&P BSE Sensex was down 156.97 points or 0.53% at 29,486.51. The S&P BSE Mid-Cap index was down 1.6 points or 0.01% at 14,345.27.

Bulk deal boosted volume on the scrip. On BSE, so far 2.55 lakh shares were traded in the counter as against average daily volume of 38,857 shares in the past one quarter. The stock hit a high of Rs 277.10 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 238 so far during the day. The stock had hit a record low of Rs 167 on 24 June 2016.

The stock had underperformed the market over the past one month till 12 April 2017, falling 0.98% compared with 0.68% rise in the Sensex. The scrip also underperformed the market in past one quarter, sliding 1.37% as against Sensexs 8.79% rise.

The small-cap company has equity capital of Rs 85.71 crore. Face value per share is Rs 10.

HealthCare Global Enterprises reported consolidated net profit of Rs 5.35 crore in Q3 December 2016 as compared with net loss of Rs 2.19 crore in Q3 December 2015. Net sales rose 22.6% to Rs 174.53 crore in Q3 December 2016 over Q3 December 2015.

HealthCare Global Enterprises is a provider of speciality healthcare in India, focused on cancer and fertility.

Powered by Capital Market - Live News

Omkar Speciality jumps after NCLT OKs scheme of arrangement
Apr 13,2017

The announcement was made during trading hours today, 13 April 2017.

Meanwhile, the S&P BSE Sensex was down 129.63 points, or 0.44% to 29,513.85.

On the BSE, 1.97 lakh shares were traded in the counter so far, compared with average daily volumes of 37,870 shares in the past one quarter. The stock had hit a high of Rs 183.20 and a low of Rs 166.10 so far during the day.

The stock hit a 52-week high of Rs 197.50 on 13 April 2016. The stock hit a 52-week low of Rs 130.05 on 9 November 2016.

The stock had outperformed the market over the past one month till 12 April 2017, rising 5.42% compared with 0.68% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, rising 1.16% as against Sensexs 8.79% rise.

The small-cap company has equity capital of Rs 20.58 crore. Face value per share is Rs 10.

Omkar Speciality Chemicals announced that the National Company Law Tribunal (NCLT), Mumbai Bench passed an order on 13 April 2017 sanctioning the composite scheme of arrangement between Omkar Speciality Chemicals, Lasa Laboratory, Urdhwa Chemicals Company, Rishichem Research, Desh Chemicals and Lasa Supergenerics and their respective shareholders and creditors.

On a consolidated basis, net profit of Omkar Speciality Chemicals rose 11.81% to Rs 10.51 crore on 16.01% rise in net sales to Rs 125.69 crore in Q3 December 2016 over Q3 December 2015.

Omkar Speciality Chemicals is primarily engaged in the production of specialty chemicals and pharma intermediates.

Powered by Capital Market - Live News

Volumes jump at FDC counter
Apr 13,2017

FDC clocked volume of 8.68 lakh shares by 14:41 IST on BSE, a 81.49-times surge over two-week average daily volume of 11,000 shares. The stock rose 1.03% to Rs 202.05.

20 Microns notched up volume of 16.14 lakh shares, a 53.98-fold surge over two-week average daily volume of 30,000 shares. The stock jumped 20% to Rs 47.90.

HealthCare Global Enterprises saw volume of 2.54 lakh shares, a 45.77-fold surge over two-week average daily volume of 6,000 shares. The stock surged 8.06% to Rs 257.30.

Ramco Cements clocked volume of 2.07 lakh shares, a 12.02-fold surge over two-week average daily volume of 17,000 shares. The stock rose 1.93% to Rs 676.

Eveready Industries India saw volume of 4.35 lakh shares, a 10.28-fold rise over two-week average daily volume of 42,000 shares. The stock rose 2.11% to Rs 291.

Powered by Capital Market - Live News

Aditya Birla Money declines on profit booking
Apr 13,2017

Meanwhile, the S&P BSE Sensex was down 122.77 points, or 0.41% at 29,520.71. The S&P BSE Small-cap index was up 56.74 points, 0.38% at 14,909.01.

High volumes were witnessed on the counter. On the BSE, 2.25 lakh shares were traded on the counter so far as against the average daily volumes of 57,938 shares in the past one quarter. The stock had hit a high of Rs 69.60 so far during the day, which is also its 52-week high. The stock had hit a low of Rs 63 so far during the day.

The stock had hit a 52-week low of Rs 20.50 on 20 April 2016. The stock had outperformed the market over the past one month till 12 April 2017, advancing 133.86% compared with the Sensexs 2.41% rise. The scrip had also outperformed the market over the past one quarter advancing 145.56% as against the Sensexs 8.79% rise.

The small-cap company has equity capital of Rs 5.54 crore. Face value per share is Rs 1.

Aditya Birla Money had rallied 118.45% in the preceding ten trading sessions to settle at Rs 66.30 yesterday, 12 April 2017, from its closing of Rs 30.35 on 28 March 2017.

Aditya Birla Money had issued a clarification to the stock exchanges on 7 April 2017 regarding sudden jump in its share price. The company said that there is no price sensitive information/announcement (including pending announcement) relating to the company which may have a bearing on the price/volume behavior in the scrip.

Aditya Birla Money reported net profit of Rs 2.76 crore in Q3 December 2016, as against net loss of Rs 0.38 crore in Q3 December 2015. Total income rose 11.6% to Rs 31.31 crore in Q3 December 2016 over Q3 December 2015.

Aditya Birla Money is engaged in the business of broking and related activities. The companys business is to provide brokerage services and portfolio management services (PMS) to its clients in the capital markets within India.

Powered by Capital Market - Live News